Intracameral cefuroxime and moxifoxacin used as endophthalmitis prophylaxis after cataract surgery: Systematic review of effectiveness and cost-effectiveness

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 1515-1522

  Linertová, Renata ^a,b   Abreu González, Rodrigo ^c   García Pérez, Lidia ^a,b   Alonso Plasencia, Marta ^c   Cordovés Dorta, Luis Mateo ^d   Abreu Reyes, José Augusto ^d   Serrano Aguilar, Pedro ^b,e  

^a Fundación Canaria de investigación y Salud FUNCiS Santa Cruz de Tenerife   (Spain)

^b Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Oeste   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^e Canary Islands Health Service   (Spain)

Author keywords

Antibiotics; Cefuroxime; Endophthalmitis; Intracameral; Moxifoxacin; Prophylaxis; Systematic review

Indexed keywords

CEFAZOLIN; CEFUROXIME; CIPROFLOXACIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; POLYMYXIN; SULFACETAMIDE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

CATARACT; CATARACT EXTRACTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; DRUG EFFICACY; ECONOMIC EVALUATION; ENDOPHTHALMITIS; HUMAN; INCIDENCE; INFORMATION PROCESSING; META ANALYSIS; MULTICENTER STUDY (TOPIC); POLYMERASE CHAIN REACTION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84907315524     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S59776     Document Type: Review

References (33)

1. ESCRS guidelines on prevention, investigation and management of post-operative endophthalmitis [webpage on the Internet]. The European Society for Cataract and Refractive Surgeons; 2007. Available from: http://www.chulaophthalmology.org/userfles/download/ESCRS_Guidelines_2007.pdf. Accessed February 1, 2013.
2. ESCRS guidelines on prevention and treatment of endophthalmitis following cataract surgery [webpage on the Internet]. The European Society for Cataract and Refractive Surgeons; 2013. Available from: http://www.escrs.org/endophthalmitis/guidelines/ENGLISH.pdf. Accessed January 15, 2014.
3. Maltezou HC, Pappa O, Nikolopoulos G, et al. Post-cataract surgery endophthalmitis outbreak caused by multidrug-resistant Pseudomonas aeruginosa. Am J Infect Control. 2012;40(1):75-77.
4. Fintelmann RE, Naseri A. Prophylaxis of postoperative endophthalmitis following cataract surgery. Drugs. 2010;70(11):1395-1409.
5. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-1775.
6. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS mul-ticenter study and identifcation of risk factors. J Cataract Refract Surg. 2007;3:978-988.
7. Wu PC, Li M, Chang SJ. Risk of endophthalmitis after cataract surgery using different protocols for povidone-iodine preoperative disinfection. J Ocul Pharmacol Ther. 2006;22(1):54-61.
8. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime. Effcacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:977-981.
9. Wejde G, Montan P, Lundström M, Stenevi U, Thorburn W. Endophthal-mitis following cataract surgery in Sweden: national prospective survey 1999-2001. Acta Ophthalmol Scand. 2005;83:7-10.
10. Gimbel HV, Sun R, DeBrof BM. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Ref Surg. 1994;6:280-285.
11. O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifoxacin. J Cataract Refract Surg. 2007;33:1790-1800.
12. Linertová R, Abreu González R, García-Pérez L, Alonso Plasencia M. Proflaxis de la endoftalmitis postquirúrgica en cirugía del cristalino: cefuroxima y moxifoxacino intracamerular. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social e Igualdad [Prophylaxis of postoperative endophthalmitis in the lens surgery: Intracameral cefuroxime and moxifoxacine]. Servicio de Evaluación del Servicio Canario de la Salud; 2011. Informes de Evalu-ación de Tecnologías Sanitarias: SESCS No 2010/04. Spanish.
13. CASP España. Programa de Lectura Crítica CASPe. Entendiendo la evidencia sobre la efcacia clínica. 11 preguntas para ayudarte a entender un estudio de cohortes [Critical Appraisal Skills Programme Spain. Understanding clinical efficacy evidence. 11 questions to help you understand a cohort study]. Available at: http://www.redcaspe.org/drupal/?q=node/29. Accessed July 7, 2014. Spanish.
14. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW; ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006;32:407-410.
15. García-Sáenz MC, Arias-Puente A, Rodríguez-Caravaca G, Bañuelos JB. Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery. Ten-year comparative study. J Cataract Refract Surg. 2010;36:203-207.
16. Sobaci G, Uysal Y, Mutlu FM, Bayer A, Gungor R, Karagul S. Prophylactic usage of intracameral cefuroxime in the prevention of postoperative endophthalmitis. Klin Monbl Augenheilkd. 2009;5:265-267.
17. García Collado C, Morillo Verdugo R, Montes Escalante I, Muñoz Muñoz N, Artacho Criado S, Dorantes Calderón B. Cefuroxima 1 mg/0,1 mL en cámara anterior para proflaxis de endoftalmitis post-quirúrgica en cirugía de cataratas [Intracameral 1 mg/0,1 mL cefuroxime in postoperative endophthalmitis prophylaxis in cataract surgery]. Aten Farm. 2008;10(1):44-47. Spanish.
18. Sharif E, Porco TC, Naseri A. Cost-effectiveness analysis of intracam-eral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery. Ophthalmology. 2009;116:1887-1896.
19. Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013;39(1):8-14.
20. Barreau G, Mounier M, Marin B, Adenis JP, Robert PY. Intracam-eral cefuroxime injection at the end of cataract surgery to reduce the incidence of endophthalmitis: French study. J Cataract Refract Surg. 2012;38(8):1370-1375.
21. Shorstein N, Winthrop K, Herrinton L. Reply: intracameral antibiotics and endophthalmitis incidence. J Cataract Refract Surg. 2013;39(2):313.
22. Fintelmann RE, Naseri A. Prophylaxis of postoperative endophthalmitis following cataract surgery. Drugs. 2010;70(11):1395-1409.
23. Behndig A, Montan P, Stenevi U, Kugelberg M, Lundström M. One million cataract surgeries: Swedish National Cataract Register 1992-2009. J Cataract Refract Surg. 2011;37:1539-1545.
24. Arshinoff SA, Bastianelli PA. Incidence of postoperative endophthal-mitis after immediate sequential bilateral cataract surgery. J Cataract Refract Surg. 2011;37(12):2105-2114.
25. Sarikkola AU, Uusitalo RJ, Hellstedt T, et al. Simultaneous bilateral versus sequential bilateral cataract surgery: Helsinki Simultaneous Bilateral Cataract Surgery Study Report 1. J Cataract Refract Surg. 2011;37(6):992-1002.
26. Serrano-Aguilar P, Ramallo-Fariña Y, Cabrera-Hernández JM, et al. Immediately sequential versus delayed sequential bilateral cataract surgery: safety and effectiveness. J Cataract Refract Surg. 2012;38(10):1734-1742.
27. Miller JJ, Scott IU, Flynn Jr H W. Acute-onset endophthalmitis after cataract surgery (2000-2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139(6):983-987.
28. Ang GS, Barras C W. Prophylaxis against infection in cataract surgery: a Surrey of Soutine practice. Eur J Ophthalmol. 2006;16:394-400.
29. Barry P. Intracameral antibiotic prophylaxis: American paper mirrors European experience. J Cataract Refract Surg. 2013;39(1):2-3.
30. Lane SS, Osher RH, Masket S, Belani S. Evaluation of the safety of prophylactic intracameral moxifoxacin in cataract surgery. J Cataract Refract Surg. 2008;34:1451-1459.
31. VIGAMOX® (moxifoxacin hydrochloride ophthalmic solution) Highlights of prescribing information [webpage on the internet]. TX: Alcon Laboratories, Inc.; 2011 [Updated July, 2011]. Available from: http://ecatalog.alcon.com/pi/Vigamox_us_en.pdf. Accessed May 7, 2014.
32. Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery; results of the 2007 ASCRS member survey; the ASCRS Cataract Clinical Committee. J Cataract Refract Surg. 2007;33:1801-1805.
33. Protocole d'utilisation therapeutique et de recueil d'informations. Aprokam 50 mg, poudre pour solution injectable (céfuroxime) [Therapeutic protocol use and information collection. Aprokam 50 mg powder for solution for injection (cefuroxime)]. Available from: http://ansm.sante.fr/var/ansm_site/storage/original/application/90a18ec1748dba109c2b6efe77ec6775.pdf. Accessed July 7, 2014. French.